Skip to content

Intraoperative temperature monitoring with zero heat flux technology (3M SpotOn sensor) in comparison with tympanic and oesophageal temperature and hypothermia risk factors: an observational study

Intraoperative temperature monitoring with zero heat flux technology (3M SpotOn sensor) in comparison with tympanic and oesophageal temperature and hypothermia risk factors: an observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN14027708
Enrollment
100
Registered
2018-07-12
Start date
2015-10-01
Completion date
Unknown
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparison of three temperature measurements and detection of hypothermia risk factors Injury, Occupational Diseases, Poisoning Hypothermia

Interventions

The hospital records and anesthesia cards of patients who had undergone major abdominal cancer surgery in the trialists' institution, in whom the SpotOn zero heat flux method, tympanic membrane measur
the exclusion criterion was defined as the absence of recorded data. In the intervention group, patients were warmed up according to a standard protocol. According to this protocol, w
patients were warmed up with FAW systems (3M Bair Hugger™ Temperature Management Blanket, Arizant Healthcare Inc., a 3M company. MN, USA) actively adjusted to 43°C for 30. Then patients transferred to

Sponsors

Dokuz Eylül University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who had undergone major abdominal cancer surgery in the trialists' institution, in whom the SpotOn zero heat flux method, tympanic membrane measurement method and esophageal temperature measurement method had all been used

Exclusion criteria

Exclusion criteria: Absence of recorded data

Design outcomes

Primary

MeasureTime frame
Body temperature measured preoperative, before anesthesia induction, following intubation, 60 min, and every one hour until the surgery, after surgery, in the entry to the recovery room and before discharge to the ward

Secondary

MeasureTime frame
Demographic and preoperative/postoperative measurements (age, gender, weight, body mass index, comorbidities, smoking history, preoperative hemoglobin and albumin levels, the amount of perioperatively administered colloids and colloids, American Society of Anesthesiologist (ASA) physical status classifications of patients type of anesthesia, central catheter usage, patient warming, duration of the operation, operating room temperature, pulse rate, arterial blood pressure, amount of blood loss, transfused red blood cells (RBS) (units) and fresh frozen plasma (FFP) (units), and postoperative hemoglobin and albumin levels)

Countries

Turkey

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026